Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease
No specific or efficient treatment exists for Alport syndrome, an X-linked hereditary disease caused by mutations in collagen type IV, a crucial component of the glomerular basement membrane. Kidney failure is usually a major complication of the disease, and patients require renal replacement therap...
Saved in:
Main Authors: | H. Trimarchi, R. Canzonieri, A. Muryan, A. Schiel, A. Araoz, M. Paulero, J. Andrews, T. Rengel, M. Forrester, F. Lombi, V. Pomeranz, R. Iriarte, E. Zotta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2016/1492743 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
by: H. Trimarchi, et al.
Published: (2017-01-01) -
Copious Podocyturia without Proteinuria and with Normal Renal Function in a Young Adult with Fabry Disease
by: H. Trimarchi, et al.
Published: (2015-01-01) -
Incidentally Diagnosed Alport Syndrome in a Patient with Drug-Induced Vasculitis
by: D. Lai, et al.
Published: (2019-01-01) -
Amiloride-Sensitive Sodium Channels and Pulmonary Edema
by: Mike Althaus, et al.
Published: (2011-01-01) -
Chiral clues to lipid identity
by: Ujjalkumar S. Das, et al.
Published: (2025-01-01)